What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
4.53%Above 5Y avg (4.34%)
Annual Rate
CNY 0.84Paid quarterly
Payout Ratio
42.9%Sustainable
Payback Period
18.0 yr
Last Ex-Dividend
Jun 2, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
41.01BCNY
6.09B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
12.63x
Updated Aug 20, 2026
Revenue (TTM)
15.44BCNY
2.29B · vs all stocks (USD)
Updated Aug 20, 2026
Profit Margin
20.88%
Updated Aug 20, 2026
Beta
0.7170x
vs all stocks
Updated Aug 20, 2026
52-Week Change
6.31%
vs all stocks
Updated Aug 20, 2026
Forward Annual Dividend Yield
4.53%
vs all stocks
Updated Aug 20, 2026
Market Capitalization
41.01BCNY
6.09B · vs all stocks (USD)
Updated Aug 20, 2026
Enterprise Value
36.66BCNY
5.44B · vs all stocks (USD)
Updated Aug 20, 2026
Trailing P/E
12.63x
Updated Aug 20, 2026
Forward P/E
12.22x
Updated Aug 20, 2026
Price to Sales (TTM)
2.66x
Updated Aug 20, 2026
Price to Book (MRQ)
2.82x
Updated Aug 20, 2026
Enterprise to Revenue
2.37x
Updated Aug 20, 2026
Enterprise to EBITDA
11.03x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 10.66×.Updated Aug 20, 2026
Gross Margin
77.88%
Updated Aug 20, 2026
Profit Margin
20.88%
Updated Aug 20, 2026
Operating Margin
18.42%
Updated Aug 20, 2026
Return on Assets (TTM)
9.44%
Updated Aug 20, 2026
Return on Equity (TTM)
22.84%
Updated Aug 20, 2026
Revenue (TTM)
15.44BCNY
2.29B · vs all stocks (USD)
Updated Aug 20, 2026
Revenue per Share (TTM)
7.04CNYUpdated Aug 20, 2026
Quarterly Revenue Growth
-12.30%
Updated Aug 20, 2026
Gross Profit (TTM)
11.73BCNY
1.74B · vs all stocks (USD)
Updated Aug 20, 2026
EBITDA (TTM)
3.44BCNY
510.73M · vs all stocks (USD)
Updated Aug 20, 2026
Net Income (TTM)
3.22BCNY
478.88M · vs all stocks (USD)
Updated Aug 20, 2026
Quarterly Earnings Growth (YoY)
59.00%
Updated Aug 20, 2026
Operating Cash Flow (TTM)
3.32BCNY
493.48M · vs all stocks (USD)
Updated Aug 20, 2026
Levered Free Cash Flow (TTM)
2.07BCNY
307.00M · vs all stocks (USD)
Updated Aug 20, 2026
Forward Annual Dividend Rate
0.8400CNYUpdated Aug 20, 2026
Forward Annual Dividend Yield
4.53%
vs all stocks
Updated Aug 20, 2026
Trailing Annual Dividend Rate
1.03CNYUpdated Aug 20, 2026
Trailing Annual Dividend Yield
5.55%
vs all stocks
Updated Aug 20, 2026
5-Year Average Dividend Yield
4.34%
vs all stocks
Updated Aug 20, 2026
Payout Ratio
42.86%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 70.07%.Updated Aug 20, 2026
Minority Interest (Equity)
135.36MCNYFY2025 · Dec 31, 2025
Revenue
15.97BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
3.85BCNYFY2025 · Dec 31, 2025
Gross Profit
12.11BCNYFY2025 · Dec 31, 2025
Operating Income
3.09BCNY
459.62M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
3.39BCNYFY2025 · Dec 31, 2025
Income Tax Expense
486.41MCNYFY2025 · Dec 31, 2025
Net Income
2.90BCNYFY2025 · Dec 31, 2025
EBIT
3.44BCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
3.57BCNYFY2025 · Dec 31, 2025
Research & Development
685.58MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
7.34BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
51.77MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
210.79MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
55.53MCNYFY2025 · Dec 31, 2025
EPS (Basic)
1.32CNYFY2025 · Dec 31, 2025
EPS (Diluted)
1.32CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
2.20BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
2.20BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
2.90BCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
1.28MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
2.74BCNYFY2025 · Dec 31, 2025
Free Cash Flow
2.39BCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
1.50BCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
2.90BCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-10.10MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-81.05MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-64.58MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-353.41MCNYFY2025 · Dec 31, 2025
Net Acquisitions
18.77KCNYFY2025 · Dec 31, 2025
Purchase of Investments
-534.78MCNYFY2025 · Dec 31, 2025
Sale of Investments
646.77MCNYFY2025 · Dec 31, 2025
Other Investing Activity
-2.64BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-2.88BCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
5.82BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-4.51BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-2.26BCNYFY2025 · Dec 31, 2025
Other Financing Charges
253.40MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-691.38MCNYFY2025 · Dec 31, 2025
Shares Outstanding
2.21BSharesUpdated Aug 20, 2026
Float Shares
1.30BSharesUpdated Aug 20, 2026
% Held by Insiders
40.27%
vs all stocks
Updated Aug 20, 2026
% Held by Institutions
11.64%
vs all stocks
Updated Aug 20, 2026
Total Cash (MRQ)
7.43BCNY
1.10B · vs all stocks (USD)
Updated Aug 20, 2026
Total Cash per Share (MRQ)
3.38CNYUpdated Aug 20, 2026
Total Debt (MRQ)
3.13BCNY
464.69M · vs all stocks (USD)
Updated Aug 20, 2026
Total Debt to Equity (MRQ)
0.2138x
Updated Aug 20, 2026
Current Ratio (MRQ)
1.34x
Updated Aug 20, 2026
Book Value per Share (MRQ)
6.59CNYUpdated Aug 20, 2026
Total Assets
22.32BCNY
3.31B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
10.77BCNYFY2025 · Dec 31, 2025
Total Liabilities
8.65BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
11.54BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
97.22MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
8.55BCNYFY2025 · Dec 31, 2025
Cash
4.11BCNYFY2025 · Dec 31, 2025
Cash Equivalents
16.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
4.12BCNYFY2025 · Dec 31, 2025
Other Short-term Investments
3.22BCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.12BCNYFY2025 · Dec 31, 2025
Inventory
474.95MCNYFY2025 · Dec 31, 2025
Accounts Payable
2.72BCNYFY2025 · Dec 31, 2025
Short-term Debt
3.97BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
66.92MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.45MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
2.21BCNYFY2025 · Dec 31, 2025
Retained Earnings
8.57BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
13.67BCNY
2.03B · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
300.52MCNYFY2025 · Dec 31, 2025
52-Week Low
17.10CNYUpdated Aug 20, 2026
52-Week High
31.01CNYUpdated Aug 20, 2026
52-Week Change
6.31%
vs all stocks
Updated Aug 20, 2026
Beta
0.7170x
vs all stocks
Updated Aug 20, 2026
50-Day MA
18.87CNYUpdated Aug 20, 2026
200-Day MA
21.85CNYUpdated Aug 20, 2026
Avg 10-Day Volume
38.19MSharesUpdated Aug 20, 2026
Avg 30-Day Volume
49.11MSharesUpdated Aug 20, 2026
Diluted EPS (TTM)
1.47CNYUpdated Aug 20, 2026
3 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Industry-Benchmarked ROA and Margin Elevated
Returns and margins have sat in the top of its industry across five years.
Reads
Industry-Benchmarked Return on Capital Elevated
It earns more on its assets and its equity than its industry, and gets more sales from those assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 4.73: safe zoneNotable
Altman Z-Score: 4.73
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $6.09B, above the global median of $1.15BNotable
Market cap (USD): 6,091,530,958.575Global Median: 1,146,734,693.424
Revenue is $2.29B, above the global median of $520.53MNotable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin Elevated
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin Elevated
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesIndustry-Benchmarked Return on Capital ElevatedIndustry-Benchmarked ROA and Margin Elevated